Diabetic Neuropathy Market to expand at a CAGR of 5.6% through 2025 | Arbor Pharmaceuticals, LLC, Pfizer, Inc., Janssen Global Services, LLC
Over the years, incidence of diabetes has increased globally. As of 2019, nearly one-tenth of the global population was afflicted by this deadly disease. Adoption [read full press release…]
